Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon
- PMID: 6204001
- PMCID: PMC2187416
- DOI: 10.1084/jem.160.1.255
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon
Abstract
IFN-gamma is known to induce expression of Ia antigens on a variety of cell types. In the present study, this activity of IFN-gamma has been analyzed with a panel of 36 melanoma cell lines, normal melanocytes, and 97 cell lines representing a range of other differentiation lineages. 55% of the melanoma cell lines express Ia antigens in a constitutive manner without IFN-gamma induction. Of the 16 Ia-melanoma lines, 13 could be induced to express Ia antigens by IFN-gamma, whereas three were noninducible. Melanocytes, which do not normally express Ia antigens, are converted to Ia expression by IFN-gamma. Ia antigens expressed constitutively or after IFN-gamma induction were identified with antibodies detecting monomorphic and allomorphic products of DR and DC loci. IFN-gamma appeared to be unique in its ability to induce Ia expression on melanoma and melanocytes; 14 other agents (including IFN-alpha and IFN-beta) known to influence growth or differentiation did not have Ia-inducing activity. Equally striking is the restriction of antigenic changes following IFN-gamma induction to HLA-associated products; of the 38 systems of cell surface antigens examined, only HLA-A,B,C, beta 2m, and Ia antigens were affected. A variety of other Ia- cell types were shown to be Ia-inducible by IFN-gamma; these included established lines of breast, colon, pancreas, bladder, kidney, ovary, and brain cancers, and cultures of normal fibroblasts, kidney epithelia, and epidermal keratinocytes. In contrast, three tumor types, teratocarcinoma, choriocarcinoma, and neuroblastoma, were not inducible for Ia expression, even though IFN-gamma could induce expression of HLA-A,B,C products. The broad representation of Ia antigens on most somatic cell types expressed either constitutively or after IFN-gamma can be viewed in an immunological context (antigen presentation/immune regulatory signals) or could indicate that Ia products have functions other than those related to immune reactions.
Similar articles
-
Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.Int J Cancer. 1989 Sep 15;44(3):554-9. doi: 10.1002/ijc.2910440330. Int J Cancer. 1989. PMID: 2506138
-
HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.J Natl Cancer Inst. 1985 Jun;74(6):1261-8. J Natl Cancer Inst. 1985. PMID: 3923246
-
Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.Eur J Immunol. 1985 Feb;15(2):118-23. doi: 10.1002/eji.1830150204. Eur J Immunol. 1985. PMID: 3918869
-
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.Cancer Immunol Immunother. 2009 Sep;58(9):1507-15. doi: 10.1007/s00262-009-0701-z. Epub 2009 Apr 2. Cancer Immunol Immunother. 2009. PMID: 19340423 Free PMC article. Review.
-
Antigens of melanocytes and melanoma.Cancer Metastasis Rev. 1991 Jun;10(2):141-50. doi: 10.1007/BF00049411. Cancer Metastasis Rev. 1991. PMID: 1873854 Review.
Cited by
-
HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli.Clin Exp Immunol. 1988 Oct;74(1):75-9. Clin Exp Immunol. 1988. PMID: 3146453 Free PMC article.
-
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.J Exp Med. 1985 Nov 1;162(5):1645-64. doi: 10.1084/jem.162.5.1645. J Exp Med. 1985. PMID: 3932581 Free PMC article.
-
Advances in the immunobiology of the skin. Implications for cutaneous malignancies.Cancer Metastasis Rev. 1986;5(2):167-78. doi: 10.1007/BF00046429. Cancer Metastasis Rev. 1986. PMID: 2951033 Review.
-
The MIF receptor CD74 in diabetic podocyte injury.J Am Soc Nephrol. 2009 Feb;20(2):353-62. doi: 10.1681/ASN.2008020194. Epub 2008 Oct 8. J Am Soc Nephrol. 2009. PMID: 18842989 Free PMC article.
-
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).Clin Exp Immunol. 1991 Nov;86(2):236-9. doi: 10.1111/j.1365-2249.1991.tb05802.x. Clin Exp Immunol. 1991. PMID: 1934591 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials